Abstract
IntroductionCoronavirus disease 2019 (COVID-19), is a respiratory illness caused by the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The Clinical Blood Sciences Laboratory (CBSL) plays a key role in supporting the monitoring and management of patients with COVID-19 disease.ObjectiveTo provide a comprehensive CBSL testing protocol to support the medical management of SARS-CoV-2 infection.MethodsDescription of the biochemical, haematological and immunological tests that have a role in the assessment and monitoring of patients with COVID-19 infection.ResultsWe provide a test menu for clinical laboratories to ensure the effective monitoring, management and prognostication of COVID-19 patients in hospital.ConclusionGiven the rapidity with which patients with COVID-19 disease can deteriorate, we recommend regular testing with vigilance paid to the rate and trajectory of change in each of these parameters.
Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
